This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

The World Market For Stents (Drug-Eluting And Bare Metal Product Markets In US, EU, Japan, India, China And ROW)

Rest of the World

Revenue Forecast

 

 

 

CHAPTER SEVEN: COMPANY PROFILES

 

Abbott Laboratories

 

Biosensors International

 

Boston Scientific

 

Biotronik SE & Co.KG

 

CID Vascular

 

Elixir Medical Corporation

 

Medtronic

 

Meril Life Sciences Pvt. Ltd.

 

MicroPort Medical ( Shanghai) Co., Ltd

 

Minvasys

 

OrbusNeich

 

REVA Medical

 

Stentys S.A.

 

Terumo Corporation

 

LIST OF EXHIBITS

 

CHAPTER ONE: EXECUTIVE SUMMARY

 

Table 1-1: Top Ten Causes of Death in the World by Development Level, 2008

 

Figure 1-1: Global Market Revenues Forecast 2010-2017

 

(Bare Metal Stents, Drug Eluding Stents, Total)

 

CHAPTER TWO: CARDIOVASCULAR DISEASE OVERVIEW

 

Table 2-1: Top Ten Causes of Death in the World by Geographical Region, 2008

 

Table 2-2: Top Ten Causes of Death in the World by Development Level, 2008

 

Table 2-3: Top Ten Causes of Death in the World in High Income Countries, 2008

 

Table 2-4: Top Ten Causes of Death in the World in Middle Income Countries, 2008

 

Table 2-5: Top Ten Causes of Death in the World in Low Income Countries, 2008

 

Figure 2-1: Percentage of Deaths Related to Cardiovascular Disease in

 

the Seven Major World Markets, 2008

 

Table 2-6: Projected Deaths from Ischemic Heart Disease (IHD) and Acute

 

Myocardial Infarction (AMI) in the Seven Major World Markets, 2012

 

Table 2-7: Age-Standardized Mortality Rates for Ischemic Heart Disease (IHD)

 

and Acute Myocardial Infarction (AMI) by Gender in the Seven Major

 

World Markets, 2009

 

Table 2-8: Estimated Total Cost of Cardiovascular Disease in Europe, 2006

 

Table 2-9: Estimated Total Cost of Cardiovascular Disease in Major Markets, 2012

 

CHAPTER THREE: CORONARY STENTS OVERVIEW

 

4 of 6

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
DOW 17,102.30 +15.67 0.09%
S&P 500 1,990.56 +3.55 0.18%
NASDAQ 4,482.0620 +8.3650 0.19%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs